United Kingdom

350,806 series

SeriesLocationUnitFrequencyLatestSource
United Kingdom exports to Malta · Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or includedUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Netherlands · Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or includedUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to New Zealand · Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or includedUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Norway · Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or includedUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Saudi Arabia · Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or includedUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Singapore · Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or includedUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Spain · Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or includedUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Sweden · Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or includedUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Switzerland · Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or includedUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Türkiye · Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or includedUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to USA · Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or includedUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Canada · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Croatia · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Cyprus · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Czechia · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Denmark · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Estonia · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Finland · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to France · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Germany · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Greece · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Argentina · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to China, Hong Kong SAR · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Hungary · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Iceland · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Australia · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Indonesia · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Ireland · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Israel · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Italy · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Japan · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Austria · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Jordan · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Kenya · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Rep. of Korea · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Kuwait · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Lebanon · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Malaysia · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Malta · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Mexico · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Other Asia, nes · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Oman · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Netherlands · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to New Zealand · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Nigeria · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Norway · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Pakistan · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Poland · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Portugal · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Romania · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Russian Federation · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Saudi Arabia · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to India · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Singapore · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Slovakia · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Slovenia · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Spain · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Sweden · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Switzerland · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Brazil · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Thailand · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Türkiye · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Uganda · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to North Macedonia · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Egypt · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to USA · Blood: human and animal, antisera and other blood fractionsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Canada · Vaccines: for human medicineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to France · Vaccines: for human medicineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Germany · Vaccines: for human medicineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Argentina · Vaccines: for human medicineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Hungary · Vaccines: for human medicineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Australia · Vaccines: for human medicineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Ireland · Vaccines: for human medicineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Italy · Vaccines: for human medicineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Malta · Vaccines: for human medicineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Netherlands · Vaccines: for human medicineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Norway · Vaccines: for human medicineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Poland · Vaccines: for human medicineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Portugal · Vaccines: for human medicineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Singapore · Vaccines: for human medicineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Spain · Vaccines: for human medicineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Sweden · Vaccines: for human medicineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Switzerland · Vaccines: for human medicineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to United Arab Emirates · Vaccines: for human medicineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to USA · Vaccines: for human medicineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Czechia · Vaccines: for veterinary medicine, for other uses than against foot and mouth diseaseUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Denmark · Vaccines: for veterinary medicine, for other uses than against foot and mouth diseaseUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Finland · Vaccines: for veterinary medicine, for other uses than against foot and mouth diseaseUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to France · Vaccines: for veterinary medicine, for other uses than against foot and mouth diseaseUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Germany · Vaccines: for veterinary medicine, for other uses than against foot and mouth diseaseUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Hungary · Vaccines: for veterinary medicine, for other uses than against foot and mouth diseaseUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Australia · Vaccines: for veterinary medicine, for other uses than against foot and mouth diseaseUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Ireland · Vaccines: for veterinary medicine, for other uses than against foot and mouth diseaseUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Israel · Vaccines: for veterinary medicine, for other uses than against foot and mouth diseaseUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Italy · Vaccines: for veterinary medicine, for other uses than against foot and mouth diseaseUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Japan · Vaccines: for veterinary medicine, for other uses than against foot and mouth diseaseUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Kenya · Vaccines: for veterinary medicine, for other uses than against foot and mouth diseaseUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Malaysia · Vaccines: for veterinary medicine, for other uses than against foot and mouth diseaseUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Morocco · Vaccines: for veterinary medicine, for other uses than against foot and mouth diseaseUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Netherlands · Vaccines: for veterinary medicine, for other uses than against foot and mouth diseaseUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom: prices and trade data | Codefact Research Data